Next Article in Journal
Composition Influence on Pulmonary Delivery of Rifampicin Liposomes
Next Article in Special Issue
Organic Nitrate Maintains Bone Marrow Blood Perfusion in Ovariectomized Female Rats: A Dynamic, Contrast-Enhanced Magnetic Resonance Imaging (MRI) Study
Previous Article in Journal
Development of a Taste-Masked Orodispersible Film Containing Dimenhydrinate
Previous Article in Special Issue
Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation
Article Menu

Export Article

Open AccessReview
Pharmaceutics 2012, 4(4), 563-589; doi:10.3390/pharmaceutics4040563

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments

Department of Experimental Clinical Oncology, Aarhus University Hospital, DK-8000 Aarhus C, Denmark
Author to whom correspondence should be addressed.
Received: 29 June 2012 / Revised: 29 October 2012 / Accepted: 30 October 2012 / Published: 7 November 2012
(This article belongs to the Special Issue DCE-MRI in Preclinical Imaging)
View Full-Text   |   Download PDF [286 KB, uploaded 7 November 2012]   |  


Antivascular treatments can either be antiangiogenic or targeting established tumour vasculature. These treatments affect the tumour microvasculature and microenvironment but may not change clinical measures like tumour volume and growth. In research on antivascular treatments, information on the tumour vasculature is therefore essential. Preclinical research is often used for optimization of antivascular drugs alone or in combined treatments. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is an in vivo imaging method providing vascular information, which has become an important tool in both preclinical and clinical research. This review discusses common DCE-MRI imaging protocols and analysis methods and provides an overview of preclinical research on antivascular treatments utilizing DCE-MRI. View Full-Text
Keywords: DCE-MRI; angiogenesis inhibitors; vascular disrupting agents; preclinical studies DCE-MRI; angiogenesis inhibitors; vascular disrupting agents; preclinical studies

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Nielsen, T.; Wittenborn, T.; Horsman, M.R. Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments. Pharmaceutics 2012, 4, 563-589.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top